By Kathrin Folkendt Ecosystem, Interview, Investor, News December 18, 2023 ShareTwitterFacebookPinterest-circled Inside FemTech Fund III: How Portfolia Founder Trish Costello Leads the Charge in Women’s Health Investing
By Femtech Insider News, Reproductive Health, Research December 18, 2023 ShareTwitterFacebookPinterest-circled Kegg Unveils Study Showing Potential for Hormone-Free Birth Control Through Cervical Fluid Tracking
By Femtech Insider Menstrual Health, News, Research December 18, 2023 ShareTwitterFacebookPinterest-circled Clue Partners with Universities to Research and Address Female Health Diagnosis Gap
By Femtech Insider Menopause, News, Pharma December 18, 2023 ShareTwitterFacebookPinterest-circled Astellas’ VEOZAH Wins EC Approval to Treat Menopause-Related Hot Flashes
By Kathrin Folkendt Ecosystem, News, Opinion December 18, 2023 ShareTwitterFacebookPinterest-circled Why Amazon CTO Werner Vogels Thinks Femtech Will Take Off in 2024
By Femtech Insider Gynecological Health, Medical Device, News December 18, 2023 ShareTwitterFacebookPinterest-circled ASPIVIX Receives CE Mark for Carevix, Its Device to Lower IUD Procedural Pain
By Femtech Insider Acquisition, Breast Health, News, Oncology December 15, 2023 ShareTwitterFacebookPinterest-circled Lunit Targets US Market with $193M Acquisition of AI-Enabled Breast Cancer Detection Platform Volpara
By Femtech Insider News, Reproductive Health December 14, 2023 ShareTwitterFacebookPinterest-circled YourChoice Therapeutics Begins Landmark Trial for Hormone-Free Male Birth Control Pill
